CU23284B7 - Tiotropium novedoso conteniendo polvo inhalador - Google Patents

Tiotropium novedoso conteniendo polvo inhalador

Info

Publication number
CU23284B7
CU23284B7 CU20030082A CU20030082A CU23284B7 CU 23284 B7 CU23284 B7 CU 23284B7 CU 20030082 A CU20030082 A CU 20030082A CU 20030082 A CU20030082 A CU 20030082A CU 23284 B7 CU23284 B7 CU 23284B7
Authority
CU
Cuba
Prior art keywords
tiotropium
novedoso
inhaling powder
treatment
containing inhaling
Prior art date
Application number
CU20030082A
Other languages
English (en)
Inventor
Rolf Dorr
Georg Boeck
Michael Walz
Karoline Bechtold-Peters
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU23284(B7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of CU23284B7 publication Critical patent/CU23284B7/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención propone polvos para la inhalación conteniendo tiotropio, el proceso para la preparación del mismo así como también su uso para preparar composiciones farmacéuticas para el tratamiento de afecciones respiratorias, particularmente para el tratamiento de la COPD (enfermedad pulmonar obstructiva crónica) y el asma.</P>
CU20030082A 2000-10-12 2003-04-11 Tiotropium novedoso conteniendo polvo inhalador CU23284B7 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10050635 2000-10-12

Publications (1)

Publication Number Publication Date
CU23284B7 true CU23284B7 (es) 2008-06-30

Family

ID=7659578

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20030082A CU23284B7 (es) 2000-10-12 2003-04-11 Tiotropium novedoso conteniendo polvo inhalador

Country Status (48)

Country Link
US (4) US7070800B2 (es)
EP (2) EP1430887A1 (es)
JP (1) JP3870159B2 (es)
KR (1) KR100488644B1 (es)
CN (1) CN1210017C (es)
AP (1) AP1712A (es)
AR (1) AR031819A1 (es)
AT (1) ATE275391T1 (es)
AU (1) AU757008B2 (es)
BG (1) BG65753B1 (es)
BR (1) BR0107304A (es)
CA (1) CA2395653C (es)
CR (1) CR6937A (es)
CU (1) CU23284B7 (es)
CZ (1) CZ301465B6 (es)
DE (1) DE50103551C5 (es)
DK (1) DK1292281T3 (es)
DZ (1) DZ3477A1 (es)
EA (1) EA004034B1 (es)
EC (2) ECSP024268A (es)
EE (1) EE04414B1 (es)
EG (1) EG24139A (es)
ES (1) ES2227268T3 (es)
GE (1) GEP20063865B (es)
HR (1) HRP20020437B1 (es)
HU (1) HU226982B1 (es)
IL (2) IL149984A0 (es)
IS (1) IS2360B (es)
MA (1) MA25843A1 (es)
ME (2) MEP40108A (es)
MX (1) MXPA02005666A (es)
MY (1) MY123544A (es)
NO (1) NO331956B1 (es)
NZ (1) NZ519406A (es)
OA (1) OA12522A (es)
PE (1) PE20020577A1 (es)
PL (1) PL200063B1 (es)
PT (1) PT1292281E (es)
RS (1) RS50197B (es)
SA (1) SA01220460B1 (es)
SI (1) SI1292281T1 (es)
SK (1) SK285389B6 (es)
TR (1) TR200402367T4 (es)
TW (1) TWI285553B (es)
UA (1) UA72014C2 (es)
UY (1) UY26959A1 (es)
WO (1) WO2002030389A1 (es)
ZA (1) ZA200204378B (es)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL200063B1 (pl) 2000-10-12 2008-12-31 Boehringer Ingelheim Pharma Nowe proszki do inhalacji zawierające tiotropium
PT2283817T (pt) 2000-11-30 2016-08-22 Vectura Ltd Método de fabrico de partículas para utilização numa composição farmacêutica
AU2002220857A1 (en) 2000-11-30 2002-06-11 Vectura Limited Particles for use in a pharmaceutical composition
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10128779A1 (de) * 2001-06-13 2003-01-02 Boehringer Ingelheim Pharma Verfahren zur Reinigung von Hartgelatinekapseln
US20030008001A1 (en) * 2001-06-13 2003-01-09 Boehringer Ingelheim Pharma Kg Process for cleaning hard gelatine capsules
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
AU2003221531B2 (en) * 2002-04-04 2008-10-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
KR20060011783A (ko) * 2002-06-12 2006-02-03 에피제네시스 파마슈티칼스 아이엔씨 데하이드로에피안드로스테론 스테로이드 및항-무스카린제와 더불어 호흡기 및 폐 질환을 치료하기위한 조성물, 제제 및 키트
ATE520405T1 (de) * 2002-08-21 2011-09-15 Norton Healthcare Ltd Inhalationszusammensetzung
GB0219513D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
JP2006516531A (ja) * 2002-08-21 2006-07-06 ノートン　ヘルスケアー　リミテッド 吸入組成物
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
US20050058606A1 (en) * 2002-12-16 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing HFC solution formulations
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
JP2007517537A (ja) 2003-06-13 2007-07-05 アドバンスト インハレーション リサーチ，インコーポレイテッド 吸入用低投薬量医薬粉末
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
UY28590A1 (es) 2003-11-03 2005-06-30 Boehringer Ingelheim Int Procedimiento para la preparación de nuevas sales de tiotropio, nuevas sales de tiotropio como tales, así como las formulaciones medicamentosas que las contienen.
EP2083007B1 (de) 2003-11-03 2013-04-24 Boehringer Ingelheim International Gmbh Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
EP1691782A1 (en) * 2003-12-03 2006-08-23 Microdrug AG Medical product containing tiotropium
PL1691783T3 (pl) * 2003-12-03 2010-05-31 Boehringer Ingelheim Int Inhalator suchego proszku ze wstępnym odmierzaniem do leków wrażliwych na wilgoć
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
RU2007133547A (ru) 2005-02-10 2009-03-20 Глаксо Груп Лимитед (GB) Способы получения лактозы с использованием методов предварительной сортировки и приготовляемые из нее фармацевтические композиции
JP5227790B2 (ja) 2005-05-02 2013-07-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規結晶性臭化チオトロピウム
RU2418796C2 (ru) * 2005-06-15 2011-05-20 Берингер Ингельхайм Интернациональ Гмбх Способ получения новых солей тиотропия
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
CN101360744A (zh) * 2005-12-19 2009-02-04 西科尔公司 纯和稳定的噻托溴铵
KR101395881B1 (ko) * 2005-12-19 2014-05-21 시코르, 인크. 브롬화 티오트로피움의 신규한 형태 및 이의 제조 방법
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
US20080051582A1 (en) * 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
BRPI0814175A2 (pt) * 2007-07-27 2015-01-20 Cargill Inc Micronização de polióis
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
CA2723806C (en) 2008-05-09 2022-05-31 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
EP2172190A1 (en) 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
CA2755697A1 (en) 2009-03-17 2010-09-23 Daiichi Sankyo Company, Limited Amide derivative
JP5843777B2 (ja) 2009-10-27 2016-01-13 ホライラ， インコーポレイテッド 冷却可能なエネルギー放出アセンブリを有する送達デバイス
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
CN102711645B (zh) 2009-11-11 2016-12-28 赫莱拉公司 用于处理组织和控制狭窄的系统和装置
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
EP2575786B1 (en) 2010-06-03 2017-11-15 Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. Process for dry powder formulations
TR201007251A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Kalsiyum kanal blokörü formülasyonu.
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US20150165038A1 (en) * 2012-02-10 2015-06-18 Arven llac Sanayi Ve Ticaret A.S. Compositions comprising muscarinic receptor antagonist and sorbitol
EP2819669B1 (de) 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung
RU2522213C2 (ru) * 2012-06-07 2014-07-10 Шолекс Девелопмент Гмбх, Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащих в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
UA115989C2 (uk) 2012-07-05 2018-01-25 Арвен Айлак Санайі Ве Тіджарет А.С. Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
US10105316B2 (en) 2012-07-05 2018-10-23 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising muscarinic receptor antagonist
US20150165037A1 (en) * 2012-07-05 2015-06-18 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising corticosteroid and sorbitol
US20150224197A1 (en) * 2012-07-05 2015-08-13 Arven Ilac Sanayi Ve Ticaret A.S. Inhalation compositions
WO2014007769A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and glucose anhydrous
WO2014007772A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
EP2913332A1 (en) 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
JP2019500916A (ja) 2015-10-23 2019-01-17 アーヴェン イラチュ サナイ ヴェ ティヂャレット エー． エス．Ａｒｖｅｎ Ｉｌａｃ Ｓａｎａｙｉ Ｖｅ Ｔｉｃａｒｅｔ Ａ．Ｓ． 臭化チオトロピウムの吸入製剤のためのブリスター
KR101728116B1 (ko) * 2015-11-03 2017-04-18 한미약품 주식회사 티오트로피움 또는 이의 약학적으로 허용가능한 염을 함유하는 흡입용 건조분말 조성물
MY186270A (en) 2015-12-24 2021-07-01 Philip Morris Products Sa Flavoured nicotine powder
EA201992234A1 (ru) 2017-03-23 2020-02-05 Сингапур Хелт Сервисиз Пте Лтд Средство для профилактики миопии, лечения миопии и/или предотвращения прогрессирования миопии, включающее тиотропий в качестве активного ингредиента
EP4108230A1 (en) 2021-06-24 2022-12-28 Laboratoires SMB New dry powder composition of tiotropium for inhalation
GR1010358B (el) * 2021-09-14 2022-12-16 Elpen Ανωνυμος Εταιρεια Φαρμακευτικη Βιομηχανια, Σταθερο φαρμακευτικο σκευασμα που περιεχει βρωμιουχο τιοτροπιο, για χορηγηση απο το αναπνευστικο

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US3860618A (en) * 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
DE2540633A1 (de) * 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
DE3211185A1 (de) * 1982-03-26 1983-09-29 Boehringer Ingelheim KG, 6507 Ingelheim Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung
DE3215493A1 (de) * 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
JPS60172442A (ja) 1984-02-20 1985-09-05 Fanuc Ltd ならい加工およびνｃ加工による機械加工装置
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
AU1560692A (en) * 1991-04-08 1992-11-02 Nippon Shinyaku Co. Ltd. Capsule
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
US5770738A (en) * 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
DE4318455A1 (de) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
US5819730A (en) 1993-06-09 1998-10-13 Glaxo Wellcome Australia Ltd. Device for administering pharmaceutical substances
ES2308955T5 (es) * 1993-09-28 2012-04-03 R.P. Scherer Gmbh Fabricación de cápsulas de gelatina blanda
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
DE19515625C2 (de) * 1995-04-28 1998-02-19 Boehringer Ingelheim Kg Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
FR2757173A1 (fr) * 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
US6235725B1 (en) * 1998-10-30 2001-05-22 Baker Norton Pharmaceuticals, Inc. Methods and compositions for the prevention of tolerance to medications
DK1283036T3 (da) * 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
JP3931486B2 (ja) * 1999-06-24 2007-06-13 住友化学株式会社 ポジ型レジスト組成物
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
PL200063B1 (pl) 2000-10-12 2008-12-31 Boehringer Ingelheim Pharma Nowe proszki do inhalacji zawierające tiotropium
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) * 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10126924A1 (de) 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
US6482429B1 (en) * 2001-06-20 2002-11-19 Boehringer Ingelheim Pharmaceuticals, Inc. Stable powder inhalation dosage formulation
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
AU2003221531B2 (en) * 2002-04-04 2008-10-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation

Also Published As

Publication number Publication date
EE200200428A (et) 2003-02-17
US20020110529A1 (en) 2002-08-15
WO2002030389A1 (de) 2002-04-18
HRP20020437B1 (en) 2005-10-31
EE04414B1 (et) 2005-02-15
IS2360B (is) 2008-05-15
OA12522A (en) 2006-05-30
HU226982B1 (en) 2010-04-28
AR031819A1 (es) 2003-10-08
DZ3477A1 (es) 2002-04-18
ES2227268T3 (es) 2005-04-01
CA2395653C (en) 2006-05-09
EP1430887A1 (de) 2004-06-23
IL149984A0 (en) 2002-12-01
BG106730A (bg) 2003-03-31
PE20020577A1 (es) 2002-08-08
CA2395653A1 (en) 2002-04-18
UA72014C2 (en) 2005-01-17
ECSP024268A (es) 2002-08-01
ME00245B (me) 2011-02-10
HUP0203885A3 (en) 2005-01-28
NO331956B1 (no) 2012-05-14
CZ301465B6 (cs) 2010-03-10
BG65753B1 (bg) 2009-10-30
AU757008B2 (en) 2003-01-30
TR200402367T4 (tr) 2004-12-21
TWI285553B (en) 2007-08-21
MXPA02005666A (es) 2002-11-29
MA25843A1 (fr) 2003-07-01
GEP20063865B (en) 2006-07-10
EP1292281A1 (de) 2003-03-19
RS50197B (sr) 2009-05-06
SI1292281T1 (sl) 2004-12-31
EA004034B1 (ru) 2003-12-25
AP2003002774A0 (en) 2003-03-31
BR0107304A (pt) 2002-08-13
NO20022414L (no) 2002-05-30
SA01220460B1 (ar) 2006-10-31
MEP40108A (en) 2011-02-10
EG24139A (en) 2008-08-06
PL200063B1 (pl) 2008-12-31
SK285389B6 (sk) 2006-12-07
PT1292281E (pt) 2004-11-30
HRP20020437A2 (en) 2004-08-31
CR6937A (es) 2003-11-28
HK1051812A1 (en) 2003-08-22
KR20020063912A (ko) 2002-08-05
JP2004510805A (ja) 2004-04-08
NO20022414D0 (no) 2002-05-22
ATE275391T1 (de) 2004-09-15
UY26959A1 (es) 2002-06-20
HUP0203885A2 (hu) 2003-03-28
NZ519406A (en) 2003-07-25
CN1210017C (zh) 2005-07-13
EP1292281B1 (de) 2004-09-08
US7070800B2 (en) 2006-07-04
AP1712A (en) 2007-01-24
ZA200204378B (en) 2003-05-19
MY123544A (en) 2006-05-31
IL149984A (en) 2007-06-03
DK1292281T3 (da) 2004-10-11
US20060039868A1 (en) 2006-02-23
US20080292563A1 (en) 2008-11-27
JP3870159B2 (ja) 2007-01-17
YU36302A (sh) 2002-09-19
SK7062002A3 (en) 2002-10-08
EA200200551A1 (ru) 2002-12-26
DE50103551C5 (de) 2014-08-21
CZ20021785A3 (cs) 2002-09-11
IS6771A (is) 2003-04-08
DE50103551D1 (de) 2004-10-14
US20040228806A1 (en) 2004-11-18
PL356840A1 (en) 2004-07-12
AU8993501A (en) 2002-04-22
KR100488644B1 (ko) 2005-05-11
CN1392795A (zh) 2003-01-22
ECSP034546A (es) 2003-06-25

Similar Documents

Publication Publication Date Title
ECSP024268A (es) Nuevos polvos para inhalacion que contienen tiotropio
MY155912A (en) New inhalable powder containing tiotropium
ATE556704T1 (de) Pulverinhalator-formulierungen
MXPA02011311A (es) Composicion novedosa.
CL2007002099A1 (es) Compuestos derivados de 3h-espiro(1-benzofuran-2,4&#39;-piperidina); proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso para el tratamiento de enfermedades respiratorias, tales como epoc y asma.
RU2006132036A (ru) Комбинация и фармацевтический препарат для лечения аллергий и заболеваний дыхательных путей
HRP20050570A2 (en) Powdered medicament for inhalation comprising a tiotropium salt and salmetrol xinafoate
HK1203149A1 (en) Novel dosage form and formulation of abediterol
NO20015082D0 (no) Pulverinnåndingsapparat for kombinert medikament
CR10112A (es) Enmascaramiento del sabor de polvos.
EP2682108A3 (en) Dry Powder Inhalers Comprising a Carrier Other Than Lactose and a Ternary Component
EA201590019A1 (ru) Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
TR201000681A2 (tr) İnhalasyon yoluyla alınan kuru toz formülasyonları.
MY145166A (en) Novel tiotropium salts, process for the preparation and pharmaceutical compositions thereof
BRPI0608791B8 (pt) cápsulas para inaladores, uso de uma composição de polímero e processo para a secagem de pós para inalação
BR0210473A (pt) Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias
EA201591871A1 (ru) Фармацевтическая композиция, содержащая будесонид и формотерол
MY140890A (en) New tiotropium containing powder formulation for inhalation
WO2007046113A3 (en) Novel pharmaceutical composition comprising alkaloid and process thereof
WO2019098969A3 (en) Dry powder compositions for inhalation
WO2005013945A3 (en) Medicaments for inhalation comprising steroids and a betamimetic
TR201620103A2 (tr) İnhalasyon i̇le uygulanan formülasyonlar